Whalesbook
Mixed Quarter Driven by Segment Performance
Godrej Agrovet's fourth quarter of fiscal year 2026 showed a contrast between earnings figures: recurring EBITDA declined 5% to INR 1.4 billion, while profit after tax (PAT) grew 14% to INR 0.8 billion. This outcome was largely shaped by performance across its business units. The animal nutrition and foods divisions were strong performers, contributing positively to the overall results. Conversely, the crop protection and vegetable oil segments experienced weaker periods. A key development within crop protection was Astec achieving positive EBITDA for the quarter and fiscal year 2026, marking a significant shift from its loss in the prior year. The company's stock reflected some of these pressures, trading around ₹596.30 in early May 2026, down more than 10% year-to-date.
Market Trends and Competitive Landscape
The Indian agrochemicals sector is forecast for steady growth of 6-8% in fiscal year 2027, fueled by consistent domestic demand and expanding distribution networks. The animal feed market is also set for substantial expansion, with projected compound annual growth of 6.6% between 2026 and 2034 due to increasing protein consumption. Godrej Agrovet holds leading positions in animal feed and oil palm. However, the agrochemical sector faces global oversupply challenges, particularly from China, leading to pricing pressures. Key competitors include Avanti Feeds (P/E 28.49) and Mukka Proteins (P/E 16.00) in animal feed, while PI Industries and UPL compete in agrochemicals. Godrej Agrovet's own P/E ratio stands at approximately 24.26. The stock has traded within its 52-week range of ₹506.10 to ₹876.35 over the past year.
Analyst Sentiment and Valuation Concerns
Despite five analysts holding a 'Strong Buy' consensus and an average 12-month price target of INR 771.00, questions about future earnings persist. ICICI Securities, for instance, maintained its 'Buy' rating with a INR 900 target but reduced its FY27E and FY28E EPS estimates by 3% and 2%, respectively. This suggests that the current valuation might be factoring in future recovery, particularly for the crop protection segment, which is sensitive to weather and faces industry headwinds. Astec's recent positive results, while a recovery, are from a previously low base. Global supply issues in agrochemicals and potential geopolitical factors add to the overall risk profile.
Company Outlook for Growth
Looking ahead, Godrej Agrovet expects improving business performance over the next 12 to 18 months. This is anticipated to be driven by continued momentum in its animal feed and vegetable oil segments. The company also expects Astec's performance to recover, alongside an improved application season for crop protection products. Godrej Agrovet's diversified model is seen as a source of resilience, with the animal feed business benefiting from rising protein demand in India and the oil palm segment from favorable commodity prices. Analysts generally remain optimistic, with potential upside projections of over 30% from current consensus targets.